Lifescience Dynamics https://validator.w3.org/feed/docs/rss2.html Company culture About us One year after MFN: How US policy is reshaping the global pharma model With #IDWeek2026 approaching (October 21–24), we’ll be watching how well respiratory vaccines… AI may expand diagnostic capabilities in cardiology Our story October is Breast Cancer Awareness Month. An opportunity to recognize those… ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care PMRC West PMRC Europe PMRC East Long-Acting HIV Treatment and PrEP: How Weekly Oral and Injectable Therapies Could Change Adherence and Patient Choice Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression The Most Expensive CI Failure is Missing the Moment Your Strategic Assumption Became Wrong World EPA Conference Today marks World Retina Day. An opportunity to raise awareness of retinal disease… Today is World Alzheimer’s Day 🎗️🌸 A time to raise awareness, break the stigma… WCLC 2026: Next-generation modalities set to reshape the lung cancer landscape Alfred Reszka Peter Kelly Team September is Prostate Cancer Awareness Month, an opportunity to recognise those affected… 5 questions that could determine Alzheimer’s next chapter Chronic respiratory conditions such as COPD and asthma continue… The EU Joint Clinical Assessment in practice: Early lessons Pharma CI Europe Pharma CI USA Pharma Has More Data Than Ever, This Doesn’t Mean It Has Better Intelligence Beyond Amyloid, Part Two (of two): Delivery, Diagnostics and the Path to Combination Care Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline Immune Reset In Rheumatology: Moving Beyond Disease Suppression Toward Durable Remission Why Lifescience Dynamics? ASRS 2026 and the reshaping of advanced AMD ESHRE 2026: How reproductive ageing, personalisation and AI are reshaping fertility care Today marks World Lung Cancer Day, an opportunity to raise awareness of the most commonly… The next era of HIV care: How long-acting innovation is redefining treatment and prevention From valency to vaccine design: The changing competitive landscape in Pneumococcal vaccines Current trends and the renaissance of Alzheimer’s drug development Gutsy moves in the IBD biologics market Driving CAR-Ts for Treatment in Cancer and Immunology From Lab to Leadership: Navigating Biotech’s New Wave with Dr. Vicki Tsao Alaa Alsaafin: Pioneering Paths in Pharma for Muslim Women Breaking Barriers: The Inspiring Story of Dr. Minori Yoshida, from Island Girl to Big Pharma Pharma Strategies for Succeeding Amid Strong Headwinds How I built a global business on a budget of just £7,500 AI-Generated Drug Candidates Are Here, But Clinical Trial Wins Need More Time Lifescience Dynamics: How This Rapidly Growing Support Consultancy Helps Clients Make Better Decisions Quest For Alzheimer’s Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning Home Press